熱門資訊> 正文
美国政府天花更新后,应用DNA股票上涨
2024-09-07 03:45
- Applied DNA Sciences (NASDAQ:APDN) shares rose 17% in afternoon trading Friday after U.S. officials said the government was stepping up surveillance of the mpox virus in response to an ongoing outbreak in Africa.
- Also rising were shares of fellow mpox test maker Co-Diagnostics (NASDAQ:CODX), which edged up 2%.
- Other makers of mpox detection products include Abbott (ABT) and Roche (OTCQX:RHHBY).
- Earlier Friday, U.S. officials said during a briefing that the government was expanding surveillance along with access to mpox testing and vaccines amid an ongoing outbreak of the disease overseas. It added that no new cases of a more easily transmissible strain of the virus have been confirmed in the U.S., according to Reuters.
- Mpox, which is related to smallpox, is also known as monkeypox.
More on Applied DNA Sciences
- Mpox Stocks Have Popped, But Pickings Are Slim For The Discerning Investor
- Applied DNA Sciences, Inc. (APDN) Q3 2024 Earnings Call Transcript
- Singapore announces quarantine measures for close contacts of mpox infected patients
- UNICEF issues emergency tender to secure mpox vaccines
- Seeking Alpha’s Quant Rating on Applied DNA Sciences
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。